Skip to content

Home - Media - Press releases - 2000    
11 October 2000
ASTRAZENECA AND NOVARTIS SHAREHOLDERS APPROVE SYNGENTA TRANSACTION

AstraZeneca PLC announces that, at its Extraordinary General Meeting held in London earlier today, shareholder approval was given for the declaration and payment by the AstraZeneca Board of a dividend of Syngenta shares to holders of AstraZeneca shares on the relevant record date. The approval of this dividend will facilitate implementation of the previously announced proposed demerger of Zeneca Agrochemicals and its merger with Novartis Agribusiness to form Syngenta.

At an Extraordinary General Meeting also held today in Switzerland, the Syngenta transaction was approved by the Novartis shareholders.

Completion of the transaction, which remains subject to US competition law approval, is presently anticipated to take place in mid-November.

Further enquires to:



Steve Brown
+44 (0)20 7304 5033

Lucy Williams
+44 (0)20 7304 5034
AstraZeneca websites
Search
 Terms of use  Privacy policy    © AstraZeneca PLC 2003 - 2008